Cita APA (7a ed.)

Y, L., X, H., J, Z., & S, Z. (2021). Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma. Dove Medical Press.

Cita Chicago Style (17a ed.)

Y, Luo, Huang X, Zhan J, y Zhang S. Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma. Dove Medical Press, 2021.

Cita MLA (8a ed.)

Y, Luo, et al. Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma. Dove Medical Press, 2021.